Fertility preservation techniques, such as cryopreservation of ovarian tissue, embryos, and oocytes, offer hope for future reproduction to individuals facing conditions like cancer or severe haematologic disorders. While the scientific evidence supporting fertility preservation is limited, it shows promise, and there is a growing trend among fertility experts to extend its application to patients with benign conditions that can cause fertility issues, such as endometriosis. Some forms of endometriosis may have a negative impact on fertility, affecting the ovarian reserve, oocyte quality, and the tubo-ovarian interface. Evaluating fertility preservation in endometriosis patients reveals several key considerations. The diverse nature of endometriosis calls for tailored approaches and distinguishing between the disease and treatment effects on ovarian reserve is crucial. Fertility preservation in endometriosis is complex, demanding consideration of disease variability, treatment effects, accurate assessment, and a clear distinction between ovarian reserve and conception ability. A personalised approach is essential for optimal outcomes in this field.
DolmansM-MDemylleDMartinez-MadridB, et al. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril2005; 83: 897–901.
2.
DonnezJDolmansM-MPellicerA, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril2013; 99: 1503–1513.
3.
MoenMH.Endometriosis in women at interval sterilization. Acta Obstet Gynecol Scand1987; 66: 451–454.
4.
Mathieu d'ArgentEFerrierCZacharopoulouC, et al. Outcomes of fertility preservation in women with endometriosis: Comparison of progestin-primed ovarian stimulation versus antagonist protocols. J Ovarian Res2020; 13: 18–19.
5.
DonnezJDolmansM-M.Fertility preservation in women. N Engl J Med2018; 378: 400–401.
6.
NICE. Endometriosis: diagnosis and management | Guidance. NICE, 2017.
7.
FalconeTFlycktR.Clinical management of endometriosis. Obstet Gynecol2018; 131: 557–571.
8.
ChaggarPTellumTThanatsisN, et al. Prevalence of deep and ovarian endometriosis in women attending a general gynecology clinic: prospective cohort study. Ultrasound Obstet Gynecol2023; 61: 632–641.
9.
TanboTFedorcsakP.Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand2017; 96: 659–667.
10.
PearceCTemplemanCRossingM.Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol2012; 13(4): 385–394.
11.
KnezJBeanENijjarS, et al. Natural progression of deep pelvic endometriosis in women who opt for expectant management. Acta Obstet Gynecol Scand2023; 102: 1298–1305.
12.
SimopoulouMRapaniAGrigoriadisS, et al. Getting to know endometriosis-related infertility better: a review on how endometriosis affects oocyte quality and embryo development. Biomedicines2021; 9: 273.
13.
RizkBTurkiRLotfyH, et al. Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect?Facts Views Vis OBGYN2015; 7: 109–118.
14.
WarzechaDSzymusikIWielgosM, et al. The impact of endometriosis on the quality of life and the incidence of depression - a cohort study. Int J Environ Res Public Health2020; 17: 3641.
15.
CentiniGLazzeriLDoresD, et al. Chronic pelvic pain and quality of life in women with and without endometriosis. J Endometr Pelvic Pain Disord2013; 5: 27–33.
16.
MissmerSATuFFAgarwalSK, et al. Impact of endometriosis on life-course potential: a narrative review. Int J Gen Med2021; 14: 9–25.
17.
HaradaTKhineYMKaponisA, et al. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv2016; 71: 557–568.
18.
GordtsSCampoR.Modern approaches to surgical management of endometrioma. Best Pract Res Clin Obstet Gynaecol2019; 59: 48–55.
19.
KitajimaMDolmansMMDonnezO, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril2014; 101: 1031–1037.
20.
QiuJ-JLiuM-HZhangZ-X, et al. Transvaginal color Doppler sonography predicts ovarian interstitial fibrosis and microvascular injury in women with ovarian endometriotic cysts. Acta Obstet Gynecol Scand2012; 91: 605–612.
21.
KurodaMKurodaKArakawaA, et al. Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserve. J Obstet Gynaecol Res2012; 38: 1187–1193.
22.
LantsbergDFernandoSCohenY, et al. The role of fertility preservation in women with endometriosis: a systematic review. J Minim Invas Gynecol2020; 27: 362–372.
23.
PallacksCHirchenhainJKrüsselJS, et al. Endometriosis doubles odds for miscarriage in patients undergoing IVF or ICSI. Eur J Obstet Gynecol Reprod Biol2017; 213: 33–38.
24.
KurodaKIkemotoYOchiaiA, et al. Combination treatment of preoperative embryo cryopreservation and endoscopic surgery (surgery-ART hybrid therapy) in infertile women with diminished ovarian reserve and uterine myomas or ovarian endometriomas. J Minim Invas Gynecol2019; 26: 1369–1375.
25.
DepaloRCavalliniALorussoF, et al. Apoptosis in normal ovaries of women with and without endometriosis. Reprod Biomed Online2009; 19: 808–815.
26.
SanchezAMVanniVSBartiromoL, et al. Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res2017; 10: 43.
27.
TabibianNSwehliEBoydA, et al. Abdominal adhesions: a practical review of an often overlooked entity. Ann Med Surg2017; 15: 9–13.
28.
CoboADomingoJPérezS, et al. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol2008; 10(5): 268–273.
29.
LlarenaNCFalconeTFlycktRL.Fertility preservation in women with endometriosis. Clin Med Insights Reprod Health2019; 13.
30.
MalvezziHHernandesCPiccinatoCA, et al. Interleukin in endometriosis-associated infertility-pelvic pain: systematic review and meta-analysis. Reproduction2019; 158(1): 1–12.
31.
LiSFuXWuT, et al. Role of interleukin-6 and its receptor in endometriosis. Med Sci Monit2017; 23: 3801–3807.
32.
LyonsRADjahanbakhchOSaridoganE, et al. Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. Lancet2002; 360: 1221–1222.
33.
PapathanasiouADjahanbakhchOSaridoganE, et al. The effect of interleukin-6 on ciliary beat frequency in the human fallopian tube. Fertil Steril2008; 90: 391–394.
34.
VanakenGJBassinetLBoonM, et al. Infertility in an adult cohort with primary ciliary dyskinesia: phenotype–gene association. Eur Respir J2017; 50: 1700314.
35.
WuLHuangXWangR, et al. Increased expression of TGF-β1 contributes to the downregulation of progesterone receptor expression in the eutopic endometrium of infertile women with minimal/mild endometriosis. Reprod Sci2023. DOI: 10.1007/s43032-023-01315-8
36.
BulunSEChengYHYinP, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol2006; 248: 94–103.
37.
SzubertMKozirógEOlszakO, et al. Adenomyosis and infertility-review of medical and surgical approaches. Int J Environ Res Public Health2021; 18: 1–12.
38.
LiJJChungJPWWangS, et al. The investigation and management of adenomyosis in women who wish to improve or preserve fertility. Biomed Res Int2018; 2018: 1–12.
39.
MeiJShengXYanY, et al. Decreased Krüppel-like factor 4 in adenomyosis impairs decidualization by repressing autophagy in human endometrial stromal cells. BMC Mol Cell Biol2022; 23: 24.
40.
VannucciniSTostiCCarmonaF, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online2017; 35: 592–601.
41.
HiraokaTHirotaYOsugaY.How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights. F&S Rev2023; 4: 15–25.
42.
VrekoussisTSiafakaVTsitouA, et al. Endometriosis-related chronic pelvic pain: A mini review on pathophysiology and impact on mental health. J Endometr Pelvic Pain Disord2020; 12: 40.
43.
RagniGSomiglianaEBenedettiF, et al. Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol2005; 193: 1908–1914.
44.
GoodmanLRGoldbergJMFlycktRL, et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol2016; 215: 589.e1–589.e6.
45.
GaravagliaESalaCTaccagniG, et al. Fertility preservation in endometriosis patients: anti-Müllerian hormone is a reliable marker of the ovarian follicle density. Front Surg2017; 4: 1–6.
46.
ElizurSEChianRCHolzerHEG, et al. Cryopreservation of oocytes in a young woman with severe and symptomatic endometriosis: a new indication for fertility preservation. Fertil Steril2009; 91: 293.e1–293.e3.
47.
DolmansMMDonnezJ.Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol2021; 70: 63–80.
48.
TsoumpouIKyrgiouMGelbayaTA, et al. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril2009; 92: 75–87.
49.
KoninckxPUssiaAAdamyanL, et al. Heterogeneity of endometriosis lesions requires individualisation of diagnosis and treatment and a different approach to research and evidence based medicine. Facts Views Vis OBGYN2019; 11: 57.
50.
MoradiYShams-BeyranvandMKhateriS, et al. A systematic review on the prevalence of endometriosis in women. Indian J Med Res2021; 154: 446–454.
51.
FuchsFRaynalPSalamaS, et al. Reproductive outcome after laparoscopic treatment of endometriosis in an infertile population. J Gynecol Obstet Biol Reprod2007; 36: 354–359.
52.
CalagnaGDella CorteLGiampaolinoP, et al. Endometriosis and strategies of fertility preservation: a systematic review of the literature. Eur J Obstet Gynecol Reprod Biol2020; 254: 218–225.
53.
DolmansMMFalconeTPatrizioP.Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil Steril2020; 114: 279–280.
54.
DonnezJDolmansMMDiazC, et al. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril2015; 104: 1097–1098.
55.
MarcouxSMaheuxRBérubéS, et al. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med1997; 337: 217–222.
56.
CollinetPFritelXRevel-delhomC, et al. Management of endometriosis CNGOF / HAS clinical practice guidelines To cite this version : HAL Id : inserm-01823259 Management of endometriosis, 2018.
57.
BiacchiardiCPPianeLDCamanniM, et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online2011; 23(6): 740–746.
58.
HartRJHickeyMMaourisP, et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev2008. DOI: 10.1002/14651858.cd004992.pub3
59.
CandianiMOttolinaJPosadzkaE, et al. Assessment of ovarian reserve after cystectomy versus “one-step” laser vaporization in the treatment of ovarian endometrioma: A small randomized clinical trial. Hum Reprod2018; 33: 2205–2211.
BailleulANiroJDu CheyronJ, et al. Infertility management according to the endometriosis fertility index in patients operated for endometriosis: What is the optimal time frame?PLoS One2021; 16: 1–11.
63.
VesaliSRazaviMRezaeinejadM, et al. Endometriosis fertility index for predicting non-assisted reproductive technology pregnancy after endometriosis surgery: a systematic review and meta-analysis. BJOG2020; 127: 800–809.
64.
RaadJSonigoCTranC, et al. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study. . . and many unresolved questions. Letter to the editor. Eur J Obstet Gynecol Reprod Biol2018; 220: 140–141.
65.
SängerNMenabritoMDi Spiezo SardoA, et al. Fertility preservation counselling for women with endometriosis: a European online survey. Arch Gynecol Obstet2023; 307: 73–85.
66.
SaridoğanE.Endometriosis in teenagers. Womens Health2015; 11: 705–709.
67.
MartireFGLazzeriLConwayF, et al. Adolescence and endometriosis: symptoms, ultrasound signs and early diagnosis. Fertil Steril2020; 114: 1049–1057.
68.
TsonisOBarmpaliaZGkrozouF, et al. Endometriosis in adolescence: early manifestation of the traditional disease or a unique variant?Eur J Obstet Gynecol Reprod Biol2020; 247: 238–243.
69.
BoschEBroerSGriesingerG, et al.; The ESHRE Guideline Group on Ovarian Stimulation. ESHRE guideline: ovarian stimulation for IVF/ICSI†. Hum Reprod Open2020; 2020: hoaa009.
70.
LandersoeSKLarsenECFormanJL, et al. Ovarian reserve markers and endocrine profile during oral contraception: is there a link between the degree of ovarian suppression and AMH?Gynecol Endocrinol2020; 36: 1090–1095.
71.
AndersonRAMitchellRTKelseyTW, et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol2015; 3: 556–567.
72.
DittrichRHacklJLotzL, et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril2015; 103: 462–468.
73.
BenagliaLSomiglianaEVercelliniP, et al. The impact of IVF procedures on endometriosis recurrence. Eur J Obstet Gynecol Reprod Biol2010; 148: 49–52.
74.
ZhangJHuLBuZ, et al. Impact of uterine adenomyosis on pregnancy outcomes in women undergoing in vitro fertilization treated with a long-term pituitary downregulation protocol. Front Endocrinol2021; 12: 655803.
75.
TakahashiTHasegawaAIgarashiH, et al. Prognostic factors for patients undergoing vitrified-warmed human embryo transfer cycles: a retrospective cohort study. Hum Fertil2017; 20: 140–146.
76.
FabbriRVicentiRParadisiR, et al. Transplantation of cryopreserved ovarian tissue in a patient affected by metastatic struma ovarii and endometriosis. Gynecol Endocrinol2018; 34: 558–562.
77.
PeignéMDevoucheEFerrarettoX, et al. Higher live birth rate with stimulated rather than artificial cycle for frozen-thawed embryo transfer. Eur J Obstet Gynecol Reprod Biol2019; 243: 144–149.
78.
TanJCerrilloMCruzM, et al. Early Pregnancy Outcomes in fresh versus deferred embryo transfer cycles for endometriosis-associated infertility: a retrospective cohort study. J Clin Med2021; 10: 344.
79.
XuZChenWChenC, et al. Effect of intrauterine injection of human chorionic gonadotropin before frozen-thawed embryo transfer on pregnancy outcomes in women with endometriosis. J Int Med Res2019; 47: 2873–2880.
80.
AsogluMRCelikCBahceciM.Frozen blastocyst transfer improves the chance of live birth in women with endometrioma. Gynecol Endocrinol2020; 36: 902–906.
81.
SurreyESKatz-JaffeMKondapalliLV, et al. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression. Reprod Biomed Online2017; 35: 145–151.
82.
MohamedAMChouliarasSJonesCJ, et al. Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis. Eur J Obstet Gynecol Reprod Biol2011; 156: 177–180.
83.
SenapatiSSammelMDMorseC, et al. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril2016; 106: 164–171.e1.
84.
HeYWuHHeX, et al. Administration of atosiban in patients with endometriosis undergoing frozen–thawed embryo transfer: a prospective, randomized study. Fertil Steril2016; 106: 416–422.
85.
ZaatTZagersMMolF, et al. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev2021; 2: CD011184.
86.
DonnezJDolmansMM.Fertility preservation in women. Nat Rev Endocrinol2013; 9: 735–749.
87.
HoekmanEJLouweLARooijersM, et al. Ovarian tissue cryopreservation: low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand2020; 99: 213–221.
88.
DonnezJDolmansM-M.Fertility preservation in women. N Engl J Med2017; 377: 1657–1665.
89.
OktayKBuyukEVeeckL, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet2004; 363: 837–840.
90.
BerlandaNAlbericoDBarbaraG, et al. Exploring the relationship between endometriomas and infertility. Womens Health2015; 11: 127–135.
91.
OktayKOktemO.Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril2010; 93: 762–768.
92.
CarrilloLSeidmanDSCittadiniE, et al. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet2016; 33: 317–323.
93.
DahhanTDancetEAFMiedemaDV, et al. Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study. Hum Reprod2014; 29: 1925–1930.
94.
AbtahiNEbrahimiBFathiR, et al. An introduction to the royan human ovarian tissue bank. Int J Fertil Steril2016; 10: 261–263.
95.
SilberSJDeRosaMPinedaJ, et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod2008; 23(7): 1531–1537.
GellertSEPorsSEKristensenSG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet2018; 35: 561–570.
98.
DonnezJMartinez-MadridBJadoulP, et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update2006; 12: 519–535.
99.
FGOT. Ovarian cryopreservation: an overview of current evidence around the Globe. Curr Opin Gynecol Obŝ2021; 4: 435–445.
100.
FabbriRVicentiRMagnaniV, et al. Ovarian tissue cryopreservation and transplantation: 20 years experience in Bologna University. Front Endocrinol2022; 13: 1035109.
101.
PinelliSBasileS.Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. Biomed Res Int2018; 2018: 1–9.
102.
DonnezJDolmansM-M.Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet2015; 32(8): 1167–1170.
103.
SönmezerMTaşkınS.Fertility preservation in women with ovarian endometriosis. Womens Health2015; 11: 625–631.
104.
Van der VenHLiebenthronJBeckmannM, et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod2016; 31: 2031–2041.
105.
TulandiTAkkourK.Role of reproductive surgery in the era of assisted reproductive technology. Best Pract Res Clin Obstet Gynaecol2012; 26: 747–755.
106.
PluchinoNRomanH.Oocyte vitrification offers more space for a tailored surgical management of endometriosis. Reprod Biomed Online2020; 41(5): 753–755.
107.
ChungEHLimSLMyersE, et al. Oocyte cryopreservation versus ovarian tissue cryopreservation for adult female oncofertility patients: a cost-effectiveness study. J Assist Reprod Genet2021; 38: 2435–2443.
108.
AlioLAngioniSArenaS, et al. Endometriosis: seeking optimal management in women approaching menopause. Climacteric2019; 22: 329–338.
109.
Hirshfeld-CytronJEGrobmanWAMiladMP.Fertility preservation for social indications: a cost-based decision analysis. Fertil Steril2011; 96: S66–S70.
110.
GunnalaVSchattmanG.Oocyte vitrification for elective fertility preservation: the past, present, and future. Curr Opin Obstet Gynecol2017; 29: 59–63.
111.
HvidmanHWBangAKPriskornL, et al. Anti-Müllerian hormone levels and fecundability in women with a natural conception. Eur J Obstet Gynecol Reprod Biol2017; 217: 44–52.
